These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5008206)

  • 1. [Hyperpigmentation due to ovulation inhibitors].
    Braun-Falco EO
    Dtsch Med Wochenschr; 1972 Jan; 97(2):57-8. PubMed ID: 5008206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do 3rd-generation ovulation inhibitors have a new risk profile?].
    Heinemann LA
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):1037-9. PubMed ID: 8829903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advantages and disadvantages of hormonal pregnancy regulation (so-called ovulation inhibitors)].
    Hauser GA
    Ther Umsch; 1968 Jun; 25(6):332-7. PubMed ID: 5733262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythema nodosum due to ovulation inhibitors?].
    Riederer J
    Dtsch Med Wochenschr; 1971 Dec; 96(51):1989. PubMed ID: 5131780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythema nodosum caused by ovulation inhibitors?].
    Milbradt R
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1813-4. PubMed ID: 5115875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood coagulation, fibrinolysis, and transaminases during the action of ovulation inhibitors in and following gradational physical stress].
    Scheele K; Klaus EJ; Walter KH; Burgdörfer H
    Med Welt; 1972 Aug; 23(33):1118-20. PubMed ID: 5072962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Premalignant dysplasias due to ovulation inhibitors?].
    Mestwerdt G
    Munch Med Wochenschr; 1972 Apr; 114(16):771-3. PubMed ID: 5067886
    [No Abstract]   [Full Text] [Related]  

  • 8. [Premalignant dysplasias due to ovulation inhibitors?].
    Soost HJ
    Munch Med Wochenschr; 1972 Apr; 114(16):769-71. PubMed ID: 5067885
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonally induced changes of the portio caused by ovulation inhibitors].
    Guhr O
    Munch Med Wochenschr; 1972 Apr; 114(16):766-8. PubMed ID: 5067884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ovulation inhibitors also for patients with liver diseases?].
    Runnebaum B
    Munch Med Wochenschr; 1972 May; 114(21):1036-8. PubMed ID: 5068334
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T; Sherman V; Turner R
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract]   [Full Text] [Related]  

  • 12. Imipramine-induced hyperpigmentation: a case report and review of the literature.
    D'Agostino ML; Risser J; Robinson-Bostom L
    J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chloasma uterinum due to contraceptive agents].
    Ippen H
    Hautarzt; 1972 May; 23(5):235. PubMed ID: 5043827
    [No Abstract]   [Full Text] [Related]  

  • 15. [On inhibition of the bursting of the follicle (medical and social aspects)].
    Bayer H
    Z Arztl Fortbild (Jena); 1967 Nov; 61(22):1174-7. PubMed ID: 5585461
    [No Abstract]   [Full Text] [Related]  

  • 16. Photo quiz. Blue-gray centrofacial hyperpigmentation.
    Rubegni P; de Aloe G; Maritati E; Mondillo S
    Am Fam Physician; 2001 Apr; 63(7):1409-10. PubMed ID: 11310653
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperpigmentation and zidovudine].
    Valencia ME; López Duplá JM; Lavilla P; Gil Aguado A
    Med Clin (Barc); 1989 Mar; 92(9):357-8. PubMed ID: 2716434
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxorubicin-associated hyperpigmentation.
    Curran CF
    N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bleomycin-induced linear hyperpigmentation].
    Schuler G; Auböck J; Huber H
    Hautarzt; 1984 Jul; 35(7):383-6. PubMed ID: 6206025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.